These recommendations are based on the following:(1) a formal review and analysis of the
recently published world literature on the topic [Medline search up to June 2011];(2) the …

Aliment Pharmacol Ther 2011; 34: 274–285 Summary Background Non‐alcoholic fatty liver
disease (NAFLD) is a common cause of chronic liver disease, and its worldwide prevalence …

Guidelines; 1 (3) guideline policies of the three societies approving this document; and (4)
the experience of the authors and independent reviewers with regards to NAFLD. Intended …

The spectrum of nonalcoholic fatty liver disease (NAFLD) ranges from asymptomatic
steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. Hepatic steatosis occurs …

Non-alcoholic fatty liver disease (NAFLD) is currently not a component of the diagnostic
criteria for metabolic syndrome (MetS); however, the development of NAFLD has some …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
worldwide and affects approximately one third of adults in the United States. The disease is …

Epidemiological and clinical data have clearly demonstrated that non-alcoholic
steatohepatitis (NASH) predisposes risk to the development of hepatocellular carcinoma …

Mathematical and Statistical Approaches in Food Science and Technology offers an
accessible guide to applying statistical and mathematical technologies in the food science …

Obesity is a growing medical and public health problem worldwide. Many digestive diseases
are related to obesity. In this article, the current state of our knowledge of obesity-related …

Non-alcoholic fatty liver disease (NAFLD) is an important health issue worldwide. We aimed
to develop a simple model to determine the presence of NAFLD in a Chinese population. A …